Acadia Healthcare (ACHC) Financials

$23.52 +0.99 (+4.39%)

Closing price 04:00 PM Eastern

Extended Trading

$23.52 +0.00 (+0.02%)

As of 04:09 PM Eastern

Annual Income Statements for Acadia Healthcare

This table shows Acadia Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	256	-22	273	191	-672	109	-176	200	6.14	113
Consolidated Net Income / (Loss)	264	-16	280	196	-669	110	-175	200	4.18	111
Net Income / (Loss) Continuing Operations	264	-16	280	208	143	53	57	200	4.18	111
Total Pre-Tax Income	342	-25	374	276	184	78	67	237	33	165
Total Operating Income	458	50	422	360	309	266	252	413	214	271
Total Gross Profit	1,463	1,356	1,217	1,071	935	901	774	1,300	1,269	821
Total Revenue	3,154	2,929	2,610	2,314	2,090	2,008	1,905	2,877	2,853	1,830
Operating Revenue	3,154	2,929	2,610	2,314	2,090	2,008	1,905	2,877	2,853	1,830
Total Cost of Revenue	1,691	1,572	1,393	1,244	1,155	1,107	1,131	1,577	1,584	1,009
Operating Cost of Revenue	1,691	1,572	1,393	1,244	1,155	1,107	1,131	1,536	1,542	974
Total Operating Expenses	1,005	1,306	795	711	626	635	522	887	1,055	549
Selling, General & Admin Expense	743	671	607	529	470	464	354	642	615	323
Depreciation Expense	150	132	118	107	95	88	80	143	135	64
Other Operating Expenses / (Income)	48	47	45	39	37	35	36	77	252	115
Impairment Charge	17	9.79	0.00	24	4.75	27	0.00	0.00	0.00	-
Restructuring Charge	47	62	24	13	12	21	30	24	48	37
Other Special Charges / (Income)	0.00	384	0.00	0.00	7.23	-	22	0.81	4.25	11
Total Other Income / (Expense), net	-116	-76	-48	-84	-125	-187	-185	-176	-181	-107
Interest Expense	116	82	70	102	158	187	185	-	-	-
Interest & Investment Income	0.00	6.42	21	18	33	0.00	-	-176	-181	-107
Income Tax Expense	77	-9.70	94	68	41	25	9.91	37	29	53
Net Income / (Loss) Attributable to Noncontrolling Interest	8.87	6.01	6.89	4.93	2.93	1.20	0.26	-0.25	-1.97	-1.08
Basic Earnings per Share	$2.79	($0.24)	$3.05	$2.15	($7.65)	$1.24	($2.01)	$2.30	$0.07	$1.65
Weighted Average Basic Shares Outstanding	91.62M	90.95M	89.68M	88.77M	87.88M	87.61M	87.29M	86.95M	85.70M	68.09M
Diluted Earnings per Share	$2.78	($0.24)	$2.98	$2.10	($7.59)	$1.24	($2.01)	$2.30	$0.07	$1.64
Weighted Average Diluted Shares Outstanding	92.06M	90.95M	91.56M	90.79M	88.60M	87.82M	87.42M	87.06M	85.97M	68.39M
Weighted Average Basic & Diluted Shares Outstanding	92.91M	92.29M	91.31M	89.90M	89.04M	88.49M	87.40M	86.90M	87.80M	68.20M

This table shows Acadia Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	33	68	78	76	58	-218	72	66	61	71
Consolidated Net Income / (Loss)	34	71	81	79	60	-216	74	67	63	73
Net Income / (Loss) Continuing Operations	34	71	81	79	60	-216	74	67	63	73
Total Pre-Tax Income	38	99	106	99	80	-287	96	86	88	97
Total Operating Income	68	128	136	126	98	-271	117	106	102	107
Total Gross Profit	349	387	376	351	342	356	345	313	310	314
Total Revenue	774	816	796	768	743	750	731	704	675	667
Operating Revenue	774	816	796	768	743	750	731	704	675	667
Total Cost of Revenue	426	428	420	418	400	394	387	391	366	353
Operating Cost of Revenue	426	428	420	418	400	394	387	391	366	353
Total Operating Expenses	281	259	241	224	244	627	227	207	207	207
Selling, General & Admin Expense	194	190	186	173	170	177	166	158	160	155
Depreciation Expense	40	38	36	36	35	33	32	32	30	30
Other Operating Expenses / (Income)	12	12	12	12	12	12	12	11	12	11
Restructuring Charge	30	8.25	6.09	2.85	35	11	9.07	6.47	5.41	11
Total Other Income / (Expense), net	-30	-30	-29	-27	-18	-16	-21	-20	-14	-10
Interest Expense	30	30	29	27	-	21	21	-	19	18
Income Tax Expense	4.48	27	26	20	20	-72	23	19	25	24
Net Income / (Loss) Attributable to Noncontrolling Interest	0.91	3.24	2.34	2.39	2.03	2.19	1.25	0.54	2.02	1.95
Basic Earnings per Share	$0.35	$0.74	$0.86	$0.84	$0.63	($2.39)	$0.79	$0.73	$0.69	$0.79
Weighted Average Basic Shares Outstanding	91.62M	91.72M	91.63M	91.36M	90.95M	91.17M	91.04M	90.10M	89.68M	89.83M
Diluted Earnings per Share	$0.36	$0.74	$0.85	$0.83	$0.64	($2.39)	$0.79	$0.72	$0.65	$0.78
Weighted Average Diluted Shares Outstanding	92.06M	92.19M	92.04M	92.01M	90.95M	91.17M	91.55M	91.39M	91.56M	91.72M
Weighted Average Basic & Diluted Shares Outstanding	92.91M	92.89M	92.87M	92.77M	92.29M	92.22M	92.17M	92.03M	91.31M	90.98M

This table details how cash moves in and out of Acadia Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-24	2.42	-36	-245	325	49	-14	2.98	46	-83
Net Cash From Operating Activities	130	462	381	374	659	333	414	400	361	240
Net Cash From Continuing Operating Activities	0.00	0.00	0.00	374	503	183	226	401	372	242
Net Income / (Loss) Continuing Operations	264	-16	280	208	143	53	57	200	4.18	111
Consolidated Net Income / (Loss)	264	-16	280	196	-669	110	-175	200	4.18	111
Net Income / (Loss) Discontinued Operations	0.00	0.00	0.00	-13	-812	57	-233	-	-	-0.11
Depreciation Expense	150	132	118	107	95	88	80	143	135	64
Amortization Expense	4.09	3.32	3.26	4.07	13	12	10	9.86	10	6.71
Non-Cash Adjustments To Reconcile Net Income	117	421	-6.76	49	122	48	58	36	216	35
Changes in Operating Assets and Liabilities, net	-406	-78	-14	6.40	130	-18	19	13	6.53	26
Net Cash From Discontinued Operating Activities	0.00	0.00	0.00	0.25	156	149	188	-1.69	-10	-1.74
Net Cash From Investing Activities	-736	-397	-306	1,013	-282	-201	-361	-337	-660	-884
Net Cash From Continuing Investing Activities	0.00	0.00	0.00	0.00	-238	-148	-276	-337	-660	-884
Purchase of Property, Plant & Equipment	-690	-424	-296	-245	-225	-233	-253	-274	-348	-303
Acquisitions	-54	-0.35	-9.51	-139	0.00	-45	0.00	-18	-683	-575
Purchase of Investments	0.00	0.00	0.00	-85	0.00	105	-	-	-	-1.93
Sale of Property, Plant & Equipment	10	29	7.07	3.49	0.09	12	0.00	5.25	-	-
Divestitures	0.00	0.00	0.00	1,511	0.00	0.00	-	-	373	-
Other Investing Activities, net	-2.98	-2.16	-7.25	-33	-13	13	-23	-49	-2.47	-5.10
Net Cash From Discontinued Investing Activities	0.00	0.00	0.00	0.00	-44	-53	-85	-	-	-
Net Cash From Financing Activities	583	-63	-111	-1,637	-51	-62	-67	-60	359	564
Net Cash From Continuing Financing Activities	0.00	0.00	0.00	0.00	-48	-59	-64	-60	359	564
Repayment of Debt	-73	-56	-114	-2,581	-1,073	-134	-62	-57	-1,976	-1,378
Repurchase of Common Equity	0.00	-44	-12	16	0.18	-1.65	-3.41	-3.46	-8.85	-
Payment of Dividends	-2.97	-5.11	-1.00	-1.59	-0.92	-0.15	0.00	0.00	-	-
Issuance of Debt	655	40	0.00	925	1,025	77	0.83	0.69	1,659	1,618
Issuance of Common Equity	5.18	2.96	15	4.54	0.00	-	-	-	685	331
Net Cash From Discontinued Financing Activities	0.00	0.00	0.00	0.00	-3.25	-2.47	-3.09	-	-	-
Effect of Exchange Rate Changes	0.00	-	-	-	-	3.55	-	-	-14	-2.36
Other Net Changes in Cash	0.00	-	-	-	-	-25	-	-	-	-
Cash Interest Paid	113	81	66	94	138	173	175	159	161	87
Cash Income Taxes Paid	28	66	86	79	-	32	-	-	-	-

This table details how cash moves in and out of Acadia Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-5.84	4.98	-0.14	-23	0.48	-13	48	-34	4.23	-35
Net Cash From Operating Activities	117	163	171	-321	116	138	164	44	114	41
Net Cash From Continuing Operating Activities	-13	163	171	-321	-346	138	164	44	-267	267
Net Income / (Loss) Continuing Operations	34	71	81	79	60	-216	74	67	63	73
Consolidated Net Income / (Loss)	34	71	81	79	60	-216	74	67	63	73
Depreciation Expense	40	38	36	36	35	33	32	32	30	30
Amortization Expense	1.03	1.03	1.02	1.02	0.84	0.83	0.83	0.82	0.82	0.82
Non-Cash Adjustments To Reconcile Net Income	83	20	-7.46	22	-2.29	398	16	8.72	1.70	-22
Changes in Operating Assets and Liabilities, net	-40	33	61	-459	23	-79	41	-63	18	-40
Net Cash From Investing Activities	-203	-193	-155	-185	-110	-129	-91	-67	-92	-78
Net Cash From Continuing Investing Activities	533	-193	-155	-185	287	-129	-91	-67	214	-78
Purchase of Property, Plant & Equipment	-203	-190	-154	-142	-139	-128	-91	-67	-87	-76
Sale of Property, Plant & Equipment	0.21	0.02	1.15	9.06	29	0.01	0.21	0.41	5.29	0.11
Other Investing Activities, net	-0.04	-0.00	-2.03	-0.91	-0.23	-0.99	-0.15	-0.79	-0.45	-1.79
Net Cash From Financing Activities	81	35	-16	483	-5.65	-21	-25	-11	-17	2.04
Net Cash From Continuing Financing Activities	-502	35	-17	484	57	-21	-25	-11	94	2.04
Repayment of Debt	-15	-15	-15	-27	-5.31	-20	-25	-5.30	-15	-5.30
Repurchase of Common Equity	0.82	0.84	-	-	0.86	0.71	1.77	-48	-4.18	2.33
Issuance of Debt	95	50	-	510	-	-	-	40	-	-
Issuance of Common Equity	1.68	0.53	0.69	2.28	0.42	0.02	0.86	1.66	2.18	5.17

This table presents Acadia Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	5,957	5,359	4,988	4,768	6,499	6,879	6,173	6,425	6,025	4,279
Total Current Assets	577	596	506	495	2,523	542	450	472	428	295
Cash & Equivalents	76	100	98	134	379	100	51	67	57	11
Accounts Receivable	365	361	322	281	274	289	318	297	263	217
Other Current Assets	136	134	86	80	61	65	82	107	108	67
Plant, Property, & Equipment, net	2,853	2,267	1,952	1,771	1,623	1,500	3,108	3,048	2,704	1,709
Total Noncurrent Assets	2,526	2,496	2,530	2,502	2,353	4,837	2,614	2,905	2,893	2,275
Goodwill	2,265	2,226	2,223	2,200	2,105	2,085	2,396	2,751	2,681	2,128
Intangible Assets	70	73	76	70	69	69	89	87	83	60
Noncurrent Deferred & Refundable Income Taxes	21	6.66	2.95	3.08	3.21	3.34	3.47	3.73	3.78	49
Other Noncurrent Operating Assets	170	190	228	229	176	153	125	63	125	39
Total Liabilities & Shareholders' Equity	5,957	5,359	4,988	4,768	6,499	6,879	6,173	6,425	6,025	4,279
Total Liabilities	2,766	2,471	2,087	2,185	4,545	4,341	3,810	3,829	3,839	2,588
Total Current Liabilities	578	886	388	405	1,308	464	416	377	343	290
Short-Term Debt	77	29	21	19	153	44	34	35	35	45
Accounts Payable	233	156	105	99	88	90	118	102	80	91
Accrued Expenses	88	532	111	126	178	69	151	141	123	73
Current Employee Benefit Liabilities	155	142	125	138	125	94	113	99	105	81
Other Current Liabilities	25	26	26	23	104	18	0.00	-	-	-
Total Noncurrent Liabilities	2,188	1,585	1,699	1,780	3,236	3,877	3,394	3,452	3,496	2,298
Long-Term Debt	1,880	1,343	1,365	1,479	2,969	3,105	3,159	3,205	3,253	2,195
Noncurrent Deferred & Payable Income Tax Liabilities	84	1.93	93	74	50	23	80	80	79	24
Other Noncurrent Operating Liabilities	224	241	241	111	217	262	154	166	165	79
Redeemable Noncontrolling Interest	117	106	88	65	55	33	29	22	18	8.06
Total Equity & Noncontrolling Interests	3,074	2,782	2,813	2,517	1,899	2,505	2,333	2,573	2,168	1,683
Total Preferred & Common Equity	3,074	2,782	2,813	2,517	1,899	2,505	2,333	2,573	2,168	1,683
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,074	2,782	2,813	2,517	1,899	2,505	2,333	2,573	2,168	1,683
Common Stock	2,686	2,650	2,659	2,637	2,581	2,559	2,543	2,518	2,497	1,574
Retained Earnings	387	132	153	-120	-310	362	253	429	220	214

This table presents Acadia Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	5,870	5,678	5,517	5,346	5,150	5,044	4,943
Total Current Assets	652	645	611	703	579	538	522
Cash & Equivalents	82	77	77	100	112	64	93
Accounts Receivable	384	389	386	363	346	346	316
Other Current Assets	186	179	147	241	121	128	112
Plant, Property, & Equipment, net	2,680	2,498	2,376	2,146	2,074	1,998	1,909
Total Noncurrent Assets	2,539	2,535	2,530	2,497	2,497	2,508	2,512
Goodwill	2,265	2,261	2,261	2,226	2,223	2,223	2,208
Intangible Assets	73	73	73	74	72	76	76
Noncurrent Deferred & Refundable Income Taxes	2.71	2.74	2.78	2.85	2.89	2.92	2.98
Other Noncurrent Operating Assets	198	197	193	195	200	206	226
Total Liabilities & Shareholders' Equity	5,870	5,678	5,517	5,346	5,150	5,044	4,943
Total Liabilities	2,724	2,613	2,542	2,536	2,139	2,114	2,111
Total Current Liabilities	610	547	482	865	432	378	401
Short-Term Debt	72	67	61	27	24	21	21
Accounts Payable	201	160	156	150	149	126	116
Accrued Expenses	168	159	120	540	122	110	128
Current Employee Benefit Liabilities	141	135	118	122	111	95	110
Other Current Liabilities	27	27	27	26	26	26	26
Total Noncurrent Liabilities	2,115	2,067	2,060	1,671	1,706	1,736	1,710
Long-Term Debt	1,805	1,775	1,794	1,350	1,372	1,400	1,379
Noncurrent Deferred & Payable Income Tax Liabilities	54	37	16	70	93	93	94
Other Noncurrent Operating Liabilities	256	255	250	251	241	244	119
Redeemable Noncontrolling Interest	115	112	109	98	91	90	88
Total Equity & Noncontrolling Interests	3,032	2,953	2,866	2,713	2,921	2,840	2,744
Total Preferred & Common Equity	3,032	2,953	2,866	2,713	2,921	2,840	2,744
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,032	2,953	2,866	2,713	2,921	2,840	2,744
Common Stock	2,677	2,666	2,658	2,639	2,629	2,620	2,651
Retained Earnings	355	287	208	74	292	219	92

This table displays calculated financial ratios and metrics derived from Acadia Healthcare's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.69%	12.20%	12.79%	10.74%	4.06%	5.44%	-33.80%	0.86%	55.92%	77.50%
EBITDA Growth	228.96%	-65.77%	15.56%	12.79%	14.04%	6.68%	-39.41%	57.26%	5.25%	62.55%
EBIT Growth	810.20%	-88.08%	17.51%	16.31%	16.32%	5.47%	-38.97%	92.65%	-21.07%	55.70%
NOPAT Growth	905.92%	-88.85%	16.49%	12.72%	33.26%	-15.92%	-38.24%	1,181.39%	-85.20%	59.52%
Net Income Growth	1,788.81%	-105.59%	43.19%	129.22%	-707.69%	162.75%	-187.92%	4,679.43%	-96.25%	34.24%
EPS Growth	1,258.33%	-108.05%	41.90%	127.67%	-712.10%	161.69%	-187.39%	3,185.71%	-95.73%	9.33%
Operating Cash Flow Growth	-71.95%	21.49%	1.63%	-43.16%	97.90%	-19.60%	3.63%	10.54%	50.36%	108.53%
Free Cash Flow Firm Growth	-957.62%	-65.82%	178.27%	-181.01%	-85.57%	334.99%	12,931.96%	99.75%	21.50%	-184.17%
Invested Capital Growth	21.93%	-0.71%	3.10%	14.50%	-1.64%	-34.46%	-4.56%	6.49%	38.15%	110.04%
Revenue Q/Q Growth	1.01%	2.36%	3.24%	2.31%	69.94%	2.31%	-36.56%	0.69%	7.90%	12.54%
EBITDA Q/Q Growth	-4.08%	0.80%	-2.59%	18.34%	45.26%	12.04%	-41.25%	3.88%	6.95%	13.31%
EBIT Q/Q Growth	-6.22%	-6.97%	-3.70%	24.88%	29.68%	14.80%	-39.43%	4.41%	3.44%	13.25%
NOPAT Q/Q Growth	-4.21%	-6.97%	-4.48%	22.80%	145.42%	47.17%	-46.67%	12.28%	269.60%	12.88%
Net Income Q/Q Growth	-9.02%	-27.61%	-2.90%	129.70%	-749.52%	152.17%	-177.74%	16.50%	226.62%	11.86%
EPS Q/Q Growth	-9.15%	-4.35%	-3.87%	127.93%	-771.68%	151.24%	-177.61%	17.35%	-30.00%	7.89%
Operating Cash Flow Q/Q Growth	0.31%	0.60%	4.30%	-19.15%	11.36%	-2.50%	-0.08%	7.08%	0.98%	27.65%
Free Cash Flow Firm Q/Q Growth	-15.38%	-68.65%	197.04%	-112.58%	55.72%	348.85%	110.23%	-100.74%	31.61%	-8.34%
Invested Capital Q/Q Growth	2.65%	1.77%	-1.58%	8.94%	-34.77%	-34.82%	-6.30%	1.20%	-8.11%	4.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.38%	46.31%	46.62%	46.26%	44.76%	44.86%	40.63%	45.19%	44.48%	44.86%
EBITDA Margin	19.40%	6.35%	20.82%	20.32%	19.95%	18.21%	17.99%	19.66%	12.61%	18.68%
Operating Margin	14.53%	1.72%	16.18%	15.53%	14.79%	13.23%	13.23%	14.35%	7.51%	14.84%
EBIT Margin	14.53%	1.72%	16.18%	15.53%	14.79%	13.23%	13.23%	14.35%	7.51%	14.84%
Profit (Net Income) Margin	8.39%	-0.53%	10.73%	8.45%	-32.02%	5.48%	-9.21%	6.94%	0.15%	6.09%
Tax Burden Percent	77.36%	61.75%	74.85%	70.92%	-364.10%	140.47%	-260.38%	84.29%	12.67%	67.66%
Interest Burden Percent	74.61%	-50.37%	88.56%	76.71%	59.47%	29.50%	26.75%	57.36%	15.38%	60.68%
Effective Tax Rate	22.64%	0.00%	25.15%	24.50%	22.09%	32.00%	14.70%	15.71%	87.33%	32.40%
Return on Invested Capital (ROIC)	7.68%	0.84%	7.66%	7.13%	6.73%	3.97%	3.81%	6.22%	0.58%	6.34%
ROIC Less NNEP Spread (ROIC-NNEP)	1.97%	-3.13%	5.05%	2.20%	-61.61%	0.61%	-8.55%	1.59%	-0.26%	1.86%
Return on Net Nonoperating Assets (RNNOA)	1.02%	-1.39%	2.55%	1.49%	-36.52%	0.53%	-10.89%	2.13%	-0.37%	2.33%
Return on Equity (ROE)	8.70%	-0.54%	10.21%	8.62%	-29.79%	4.49%	-7.08%	8.35%	0.22%	8.67%
Cash Return on Invested Capital (CROIC)	-12.08%	1.56%	4.61%	-6.38%	8.38%	45.60%	8.48%	-0.07%	-31.46%	-64.64%
Operating Return on Assets (OROA)	8.10%	0.97%	8.66%	6.38%	4.62%	4.07%	4.00%	6.63%	4.16%	8.37%
Return on Assets (ROA)	4.67%	-0.30%	5.74%	3.47%	-10.00%	1.69%	-2.79%	3.21%	0.08%	3.44%
Return on Common Equity (ROCE)	8.38%	-0.52%	9.93%	8.39%	-29.20%	4.44%	-7.01%	8.28%	0.21%	8.64%
Return on Equity Simple (ROE_SIMPLE)	8.60%	-0.56%	9.96%	7.77%	-35.23%	4.40%	-7.52%	7.76%	0.19%	6.62%
Net Operating Profit after Tax (NOPAT)	355	35	316	271	241	181	215	348	27	184
NOPAT Margin	11.24%	1.20%	12.11%	11.73%	11.52%	9.00%	11.28%	12.09%	0.95%	10.03%
Net Nonoperating Expense Percent (NNEP)	5.71%	3.98%	2.61%	4.94%	68.34%	3.35%	12.36%	4.63%	0.84%	4.48%
Return On Investment Capital (ROIC_SIMPLE)	7.05%	0.85%	7.53%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	53.62%	53.69%	53.38%	53.74%	55.24%	55.14%	59.37%	54.81%	55.52%	55.14%
SG&A Expenses to Revenue	23.56%	22.91%	23.27%	22.85%	22.49%	23.08%	18.57%	22.33%	21.57%	17.67%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	31.85%	44.59%	30.44%	30.72%	29.97%	31.63%	27.41%	30.84%	36.97%	30.02%
Earnings before Interest and Taxes (EBIT)	458	50	422	360	309	266	252	413	214	271
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	612	186	543	470	417	366	343	566	360	342
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.20	2.58	2.66	2.17	2.35	1.17	0.97	1.11	1.34	2.66
Price to Tangible Book Value (P/TBV)	4.98	14.85	14.57	22.07	0.00	8.37	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.17	2.45	2.87	2.36	2.14	1.47	1.19	1.00	1.02	2.45
Price to Earnings (P/E)	14.41	0.00	27.42	28.64	0.00	27.01	0.00	14.35	471.48	39.78
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.94%	0.00%	3.65%	3.49%	0.00%	3.70%	0.00%	6.97%	0.21%	2.51%
Enterprise Value to Invested Capital (EV/IC)	1.12	2.06	2.12	1.72	2.05	1.67	0.99	1.05	1.13	1.71
Enterprise Value to Revenue (EV/Rev)	1.80	2.92	3.40	3.03	3.48	3.00	2.86	2.11	2.15	3.67
Enterprise Value to EBITDA (EV/EBITDA)	9.28	45.95	16.31	14.89	17.44	16.48	15.88	10.72	17.08	19.65
Enterprise Value to EBIT (EV/EBIT)	12.40	169.79	20.99	19.48	23.53	22.67	21.60	14.68	28.68	24.73
Enterprise Value to NOPAT (EV/NOPAT)	16.02	242.55	28.04	25.81	30.20	33.34	25.32	17.42	226.30	36.59
Enterprise Value to Operating Cash Flow (EV/OCF)	43.80	18.49	23.30	18.71	11.04	18.10	13.14	15.17	17.00	27.93
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	131.48	46.61	0.00	24.24	2.90	11.39	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.61	0.48	0.48	0.62	1.60	1.24	1.35	1.25	1.50	1.33
Long-Term Debt to Equity	0.59	0.46	0.47	0.62	1.52	1.22	1.34	1.24	1.49	1.30
Financial Leverage	0.52	0.44	0.50	0.68	0.59	0.86	1.27	1.34	1.41	1.25
Leverage Ratio	1.86	1.79	1.78	2.48	2.98	2.66	2.54	2.60	2.66	2.52
Compound Leverage Factor	1.39	-0.90	1.58	1.90	1.77	0.79	0.68	1.49	0.41	1.53
Debt to Total Capital	38.01%	32.21%	32.33%	38.46%	61.50%	55.37%	57.48%	55.52%	60.07%	56.99%
Short-Term Debt to Total Capital	1.49%	0.69%	0.50%	0.44%	3.02%	0.77%	0.61%	0.60%	0.64%	1.15%
Long-Term Debt to Total Capital	36.52%	31.52%	31.83%	38.02%	58.48%	54.60%	56.87%	54.93%	59.43%	55.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.28%	2.48%	2.06%	1.56%	1.09%	0.58%	0.52%	0.38%	0.32%	0.20%
Common Equity to Total Capital	59.71%	65.31%	65.61%	59.98%	37.41%	44.05%	42.00%	44.09%	39.61%	42.81%
Debt to EBITDA	3.20	7.37	2.55	3.43	7.49	8.61	9.32	5.73	9.14	6.56
Net Debt to EBITDA	3.07	6.84	2.37	3.15	6.58	8.34	9.17	5.61	8.98	6.52
Long-Term Debt to EBITDA	3.07	7.22	2.51	3.39	7.12	8.49	9.22	5.67	9.04	6.42
Debt to NOPAT	5.52	38.92	4.38	5.95	12.97	17.43	14.86	9.31	121.08	12.21
Net Debt to NOPAT	5.30	36.08	4.07	5.45	11.39	16.88	14.63	9.12	118.98	12.15
Long-Term Debt to NOPAT	5.30	38.09	4.32	5.88	12.33	17.19	14.70	9.21	119.80	11.96
Altman Z-Score	1.67	2.29	3.03	2.22	1.23	0.91	0.86	1.22	1.11	1.75
Noncontrolling Interest Sharing Ratio	3.67%	3.35%	2.80%	2.66%	1.97%	1.26%	1.03%	0.84%	0.67%	0.31%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.00	0.67	1.30	1.22	1.93	1.17	1.08	1.25	1.25	1.02
Quick Ratio	0.76	0.52	1.08	1.03	0.50	0.84	0.89	0.97	0.93	0.79
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-558	65	190	-243	300	2,078	478	-3.72	-1,468	-1,871
Operating Cash Flow to CapEx	19.07%	117.13%	131.65%	155.18%	292.97%	150.69%	163.55%	148.58%	103.80%	79.43%
Free Cash Flow to Firm to Interest Expense	-4.79	0.79	2.73	-2.39	1.90	11.09	2.59	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	1.11	5.63	5.46	3.68	4.17	1.78	2.24	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-4.73	0.82	1.31	1.31	2.74	0.60	0.87	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.56	0.57	0.54	0.41	0.31	0.31	0.30	0.46	0.55	0.56
Accounts Receivable Turnover	8.68	8.56	8.65	8.34	7.43	6.62	6.19	10.27	11.89	10.92
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.23	1.39	1.40	1.36	1.34	0.87	0.62	1.00	1.29	1.32
Accounts Payable Turnover	8.70	12.06	13.71	13.35	12.97	10.65	10.28	17.30	18.48	14.41
Days Sales Outstanding (DSO)	42.05	42.62	42.21	43.75	49.11	55.15	58.93	35.54	30.70	33.42
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	41.96	30.28	26.63	27.35	28.15	34.28	35.51	21.10	19.75	25.33
Cash Conversion Cycle (CCC)	0.09	12.34	15.59	16.41	20.96	20.87	23.42	14.44	10.96	8.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,071	4,159	4,189	4,063	3,549	3,608	5,505	5,768	5,416	3,921
Invested Capital Turnover	0.68	0.70	0.63	0.61	0.58	0.44	0.34	0.51	0.61	0.63
Increase / (Decrease) in Invested Capital	912	-30	126	514	-59	-1,897	-263	352	1,496	2,054
Enterprise Value (EV)	5,681	8,548	8,866	7,005	7,272	6,025	5,441	6,062	6,145	6,715
Market Capitalization	3,683	7,171	7,489	5,459	4,473	2,942	2,269	2,867	2,896	4,478
Book Value per Share	$33.09	$30.17	$30.92	$27.99	$21.34	$28.29	$26.44	$29.29	$24.77	$23.48
Tangible Book Value per Share	$7.95	$5.23	$5.65	$2.75	($3.08)	$3.97	($1.72)	($3.02)	($6.82)	($7.04)
Total Capital	5,148	4,259	4,287	4,197	5,077	5,688	5,556	5,835	5,473	3,932
Total Debt	1,957	1,372	1,386	1,614	3,122	3,149	3,193	3,240	3,288	2,241
Total Long-Term Debt	1,880	1,343	1,365	1,595	2,969	3,105	3,159	3,205	3,253	2,195
Net Debt	1,881	1,272	1,288	1,480	2,744	3,050	3,143	3,173	3,231	2,230
Capital Expenditures (CapEx)	680	395	289	241	225	221	253	269	348	303
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.08	-361	41	-25	990	23	18	62	63	39
Debt-free Net Working Capital (DFNWC)	76	-261	139	109	1,369	122	68	129	120	50
Net Working Capital (NWC)	-0.43	-290	118	90	1,215	79	34	94	85	4.53
Net Nonoperating Expense (NNE)	90	51	36	76	910	71	390	148	23	72
Net Nonoperating Obligations (NNO)	1,881	1,272	1,288	1,480	1,594	1,069	3,143	3,173	3,231	2,230
Total Depreciation and Amortization (D&A)	154	136	121	111	108	100	91	153	145	70
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-12.31%	1.59%	-1.08%	47.37%	1.13%	0.93%	2.14%	2.20%	2.11%
Debt-free Net Working Capital to Revenue	2.42%	-8.90%	5.33%	4.70%	65.49%	6.09%	3.58%	4.48%	4.20%	2.73%
Net Working Capital to Revenue	-0.01%	-9.89%	4.51%	3.90%	58.15%	3.92%	1.79%	3.27%	2.98%	0.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.79	($0.24)	$3.05	$2.15	($7.65)	$1.24	($2.01)	$2.30	$0.07	$1.65
Adjusted Weighted Average Basic Shares Outstanding	91.62M	90.95M	89.68M	88.77M	87.88M	87.61M	87.29M	86.95M	85.70M	68.09M
Adjusted Diluted Earnings per Share	$2.78	($0.24)	$2.98	$2.10	($7.59)	$1.24	($2.01)	$2.30	$0.07	$1.64
Adjusted Weighted Average Diluted Shares Outstanding	92.06M	90.95M	91.56M	90.79M	88.60M	87.82M	87.29M	87.06M	85.97M	68.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$1.24	($2.01)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	92.91M	92.29M	91.31M	89.90M	89.04M	88.49M	88.46M	87.95M	87.55M	87.22M
Normalized Net Operating Profit after Tax (NOPAT)	404	355	334	299	259	214	259	369	187	216
Normalized NOPAT Margin	12.81%	12.11%	12.79%	12.94%	12.41%	10.63%	13.60%	12.83%	6.55%	11.78%
Pre Tax Income Margin	10.84%	-0.87%	14.33%	11.92%	8.79%	3.90%	3.54%	8.23%	1.16%	9.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.94	0.61	6.06	3.54	1.95	1.42	1.37	0.00	0.00	0.00
NOPAT to Interest Expense	3.05	0.43	4.53	2.67	1.52	0.96	1.16	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-1.91	-4.19	1.91	1.16	0.53	0.24	-0.01	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-2.80	-4.38	0.39	0.30	0.10	-0.21	-0.21	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.12%	-32.61%	0.36%	0.81%	-0.14%	0.14%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.12%	-315.70%	4.54%	-7.52%	-0.11%	1.64%	-1.94%	1.73%	211.83%	0.00%

This table displays calculated financial ratios and metrics derived from Acadia Healthcare's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.23%	8.70%	8.85%	9.06%	10.00%	12.54%	12.22%	14.21%	13.79%	13.47%
EBITDA Growth	-19.33%	170.57%	15.00%	18.39%	1.11%	-271.85%	1.74%	10.58%	-9.77%	6.34%
EBIT Growth	-30.86%	147.40%	15.58%	19.33%	-3.69%	-352.30%	-0.28%	11.09%	-13.69%	6.37%
NOPAT Growth	-18.38%	149.03%	15.03%	22.36%	0.39%	-334.78%	1.79%	10.60%	-16.83%	0.53%
Net Income Growth	-43.89%	133.11%	9.88%	18.35%	-5.37%	-395.05%	-10.23%	7.51%	-11.71%	7.58%
EPS Growth	-43.75%	130.96%	7.59%	15.28%	-1.54%	-406.41%	-10.23%	7.46%	-15.58%	6.85%
Operating Cash Flow Growth	0.34%	18.33%	4.51%	-823.48%	2.43%	235.94%	9.76%	-42.17%	16.04%	-62.73%
Free Cash Flow Firm Growth	-924.39%	-3,648.20%	-500.93%	-69.79%	296.10%	95.45%	80.17%	11.42%	87.64%	-124.91%
Invested Capital Growth	21.93%	20.88%	12.40%	10.88%	-0.71%	-3.98%	3.89%	7.46%	3.10%	14.13%
Revenue Q/Q Growth	-5.08%	2.46%	3.64%	3.40%	-1.00%	2.60%	3.84%	4.29%	1.28%	2.30%
EBITDA Q/Q Growth	-35.00%	-3.21%	5.68%	21.34%	156.86%	-257.73%	8.80%	3.63%	-3.37%	-6.62%
EBIT Q/Q Growth	-47.02%	-5.26%	7.58%	28.03%	136.32%	-331.04%	11.07%	3.34%	-4.86%	-8.69%
NOPAT Q/Q Growth	-35.45%	-9.63%	2.48%	36.53%	138.77%	-312.04%	9.01%	12.01%	-9.32%	-8.07%
Net Income Q/Q Growth	-53.02%	-11.69%	2.60%	31.82%	127.73%	-393.04%	10.50%	5.41%	-13.55%	-10.85%
EPS Q/Q Growth	-51.35%	-12.94%	2.41%	29.69%	126.78%	-402.53%	9.72%	10.77%	-16.67%	-11.36%
Operating Cash Flow Q/Q Growth	-28.46%	-4.69%	153.27%	-376.25%	-15.63%	-15.82%	268.78%	-60.89%	176.69%	-72.50%
Free Cash Flow Firm Q/Q Growth	-12.06%	-76.85%	-17.43%	-454.21%	609.51%	71.65%	66.82%	-309.10%	88.19%	-23.65%
Invested Capital Q/Q Growth	2.65%	2.32%	1.57%	14.29%	1.77%	-4.86%	0.20%	2.34%	-1.58%	2.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.03%	47.51%	47.27%	45.64%	46.10%	47.47%	47.13%	44.46%	45.85%	47.12%
EBITDA Margin	14.03%	20.49%	21.70%	21.28%	18.13%	-31.57%	20.53%	19.60%	19.72%	20.67%
Operating Margin	8.79%	15.75%	17.04%	16.41%	13.26%	-36.13%	16.04%	15.00%	15.14%	16.12%
EBIT Margin	8.79%	15.75%	17.04%	16.41%	13.26%	-36.13%	16.04%	15.00%	15.14%	16.12%
Profit (Net Income) Margin	4.33%	8.75%	10.15%	10.26%	8.04%	-28.72%	10.06%	9.45%	9.35%	10.96%
Tax Burden Percent	88.22%	72.41%	75.91%	79.69%	74.73%	74.99%	76.27%	77.72%	71.70%	75.23%
Interest Burden Percent	55.83%	76.71%	78.50%	78.41%	81.21%	106.01%	82.18%	81.07%	86.15%	90.37%
Effective Tax Rate	11.78%	27.59%	24.09%	20.31%	25.27%	0.00%	23.73%	22.28%	28.30%	24.77%
Return on Invested Capital (ROIC)	5.30%	7.89%	8.67%	8.66%	6.95%	-17.35%	8.06%	7.60%	6.87%	7.68%
ROIC Less NNEP Spread (ROIC-NNEP)	3.62%	6.48%	7.21%	7.28%	5.87%	-19.25%	6.87%	6.45%	6.13%	7.09%
Return on Net Nonoperating Assets (RNNOA)	1.88%	3.34%	3.62%	3.86%	2.60%	-9.22%	3.20%	3.13%	3.10%	3.54%
Return on Equity (ROE)	7.18%	11.23%	12.29%	12.52%	9.55%	-26.56%	11.27%	10.73%	9.96%	11.21%
Cash Return on Invested Capital (CROIC)	-12.08%	-10.71%	-10.31%	-9.22%	1.56%	4.97%	3.90%	0.63%	4.61%	-4.91%
Operating Return on Assets (OROA)	4.90%	8.77%	9.62%	9.30%	7.50%	-20.09%	8.88%	8.19%	8.10%	8.54%
Return on Assets (ROA)	2.41%	4.87%	5.73%	5.81%	4.55%	-15.97%	5.57%	5.16%	5.00%	5.81%
Return on Common Equity (ROCE)	6.91%	10.83%	11.88%	12.10%	9.23%	-25.69%	10.94%	10.42%	9.68%	10.90%
Return on Equity Simple (ROE_SIMPLE)	0.00%	9.59%	0.13%	-0.12%	0.00%	-0.45%	9.46%	10.03%	0.00%	10.51%
Net Operating Profit after Tax (NOPAT)	60	93	103	100	74	-190	89	82	73	81
NOPAT Margin	7.76%	11.41%	12.93%	13.08%	9.91%	-25.29%	12.24%	11.66%	10.85%	12.12%
Net Nonoperating Expense Percent (NNEP)	1.68%	1.41%	1.45%	1.38%	1.08%	1.91%	1.19%	1.15%	0.73%	0.59%
Return On Investment Capital (ROIC_SIMPLE)	1.19%	-	-	-	1.77%	-	-	-	1.75%	-
Cost of Revenue to Revenue	54.97%	52.49%	52.73%	54.36%	53.90%	52.53%	52.87%	55.54%	54.15%	52.88%
SG&A Expenses to Revenue	25.05%	23.33%	23.32%	22.58%	22.93%	23.55%	22.68%	22.43%	23.71%	23.24%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.24%	31.75%	30.23%	29.23%	32.84%	83.60%	31.09%	29.46%	30.71%	31.00%
Earnings before Interest and Taxes (EBIT)	68	128	136	126	98	-271	117	106	102	107
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	109	167	173	163	135	-237	150	138	133	138
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.20	1.94	2.12	2.55	2.58	2.39	2.51	2.32	2.66	2.59
Price to Tangible Book Value (P/TBV)	4.98	8.49	10.14	13.74	14.85	15.70	11.70	12.21	14.57	15.44
Price to Revenue (P/Rev)	1.17	1.89	2.05	2.44	2.45	2.27	2.64	2.45	2.87	2.81
Price to Earnings (P/E)	14.41	20.98	0.00	0.00	0.00	0.00	27.09	23.70	27.42	25.16
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.94%	4.77%	0.00%	0.00%	0.00%	0.00%	3.69%	4.22%	3.65%	3.97%
Enterprise Value to Invested Capital (EV/IC)	1.12	1.58	1.69	1.93	2.06	1.92	2.03	1.88	2.12	2.02
Enterprise Value to Revenue (EV/Rev)	1.80	2.50	2.66	3.07	2.92	2.75	3.13	2.98	3.40	3.41
Enterprise Value to EBITDA (EV/EBITDA)	9.28	12.22	34.81	43.49	45.95	42.57	15.56	14.45	16.31	15.44
Enterprise Value to EBIT (EV/EBIT)	12.40	15.96	91.44	129.92	169.79	145.15	20.12	18.58	20.99	19.64
Enterprise Value to NOPAT (EV/NOPAT)	16.02	21.07	130.63	185.60	242.55	207.36	26.74	24.83	28.04	26.02
Enterprise Value to Operating Cash Flow (EV/OCF)	43.80	60.31	78.27	95.12	18.49	17.09	23.99	23.11	23.30	23.61
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	131.48	37.88	52.92	306.28	46.61	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.61	0.60	0.60	0.62	0.48	0.49	0.46	0.49	0.48	0.54
Long-Term Debt to Equity	0.59	0.57	0.58	0.60	0.46	0.48	0.46	0.48	0.47	0.53
Financial Leverage	0.52	0.52	0.50	0.53	0.44	0.48	0.47	0.48	0.50	0.50
Leverage Ratio	1.86	1.88	1.78	1.79	1.79	1.82	1.74	1.77	1.78	1.79
Compound Leverage Factor	1.04	1.44	1.40	1.40	1.45	1.93	1.43	1.44	1.53	1.62
Debt to Total Capital	38.01%	37.36%	37.53%	38.41%	32.21%	32.88%	31.68%	32.66%	32.33%	34.90%
Short-Term Debt to Total Capital	1.49%	1.43%	1.36%	1.27%	0.69%	0.63%	0.54%	0.49%	0.50%	0.49%
Long-Term Debt to Total Capital	36.52%	35.93%	36.17%	37.14%	31.52%	32.24%	31.13%	32.17%	31.83%	34.41%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.28%	2.28%	2.28%	2.26%	2.48%	2.33%	2.06%	2.08%	2.06%	2.03%
Common Equity to Total Capital	59.71%	60.36%	60.19%	59.32%	65.31%	64.79%	66.27%	65.26%	65.61%	63.07%
Debt to EBITDA	3.20	2.94	7.87	8.78	7.37	7.46	2.50	2.55	2.55	2.72
Net Debt to EBITDA	3.07	2.81	7.54	8.41	6.84	6.92	2.30	2.44	2.37	2.55
Long-Term Debt to EBITDA	3.07	2.83	7.59	8.49	7.22	7.32	2.45	2.51	2.51	2.68
Debt to NOPAT	5.52	5.07	29.54	37.46	38.92	36.34	4.29	4.39	4.38	4.59
Net Debt to NOPAT	5.30	4.85	28.30	35.90	36.08	33.71	3.94	4.19	4.07	4.30
Long-Term Debt to NOPAT	5.30	4.88	28.47	36.22	38.09	35.64	4.22	4.32	4.32	4.52
Altman Z-Score	1.46	1.99	2.15	2.42	2.32	1.88	2.78	2.58	2.82	2.66
Noncontrolling Interest Sharing Ratio	3.67%	3.56%	3.33%	3.38%	3.35%	3.29%	2.89%	2.88%	2.80%	2.82%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.00	1.07	1.18	1.27	0.67	0.81	1.34	1.42	1.30	1.30
Quick Ratio	0.76	0.76	0.85	0.96	0.52	0.53	1.06	1.08	1.08	1.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-852	-760	-430	-366	103	-20	-72	-216	-53	-446
Operating Cash Flow to CapEx	57.41%	85.76%	111.80%	-240.93%	105.79%	107.67%	180.72%	67.17%	138.36%	53.83%
Free Cash Flow to Firm to Interest Expense	-28.33	-25.41	-14.74	-13.45	0.00	-0.98	-3.42	0.00	-2.72	-24.78
Operating Cash Flow to Interest Expense	3.88	5.45	5.87	-11.81	0.00	6.65	7.83	0.00	5.85	2.28
Operating Cash Flow Less CapEx to Interest Expense	-2.88	-0.91	0.62	-16.71	0.00	0.47	3.50	0.00	1.62	-1.96
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.56	0.56	0.56	0.57	0.57	0.56	0.55	0.55	0.54	0.53
Accounts Receivable Turnover	8.68	8.36	8.32	8.17	8.56	8.43	8.60	8.36	8.65	8.45
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.23	1.29	1.34	1.37	1.39	1.41	1.41	1.42	1.40	1.42
Accounts Payable Turnover	8.70	9.48	10.58	11.34	12.06	11.56	11.49	12.60	13.71	13.36
Days Sales Outstanding (DSO)	42.05	43.64	43.89	44.68	42.62	43.29	42.45	43.66	42.21	43.17
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	41.96	38.48	34.49	32.18	30.28	31.56	31.76	28.96	26.63	27.33
Cash Conversion Cycle (CCC)	0.09	5.15	9.40	12.50	12.34	11.73	10.69	14.69	15.59	15.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,071	4,940	4,829	4,754	4,159	4,087	4,296	4,287	4,189	4,257
Invested Capital Turnover	0.68	0.69	0.67	0.66	0.70	0.69	0.66	0.65	0.63	0.63
Increase / (Decrease) in Invested Capital	912	853	533	467	-30	-169	161	298	126	527
Enterprise Value (EV)	5,681	7,798	8,142	9,193	8,548	7,855	8,704	8,045	8,866	8,615
Market Capitalization	3,683	5,889	6,266	7,305	7,171	6,481	7,330	6,597	7,489	7,102
Book Value per Share	$33.09	$32.64	$31.83	$31.37	$30.17	$29.43	$31.74	$31.10	$30.92	$30.20
Tangible Book Value per Share	$7.95	$7.47	$6.66	$5.82	$5.23	$4.48	$6.81	$5.92	$5.65	$5.06
Total Capital	5,148	5,023	4,906	4,831	4,259	4,187	4,408	4,351	4,287	4,350
Total Debt	1,957	1,877	1,841	1,856	1,372	1,377	1,396	1,421	1,386	1,518
Total Long-Term Debt	1,880	1,805	1,775	1,794	1,343	1,350	1,372	1,400	1,365	1,497
Net Debt	1,881	1,794	1,764	1,778	1,272	1,277	1,284	1,357	1,288	1,425
Capital Expenditures (CapEx)	203	190	153	133	110	128	91	66	82	76
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.08	32	88	113	-361	-234	58	117	41	48
Debt-free Net Working Capital (DFNWC)	76	114	165	190	-261	-135	170	181	139	142
Net Working Capital (NWC)	-0.43	43	99	128	-290	-161	146	160	118	121
Net Nonoperating Expense (NNE)	27	22	22	22	14	26	16	16	10	7.78
Net Nonoperating Obligations (NNO)	1,881	1,794	1,764	1,778	1,272	1,277	1,284	1,357	1,288	1,425
Total Depreciation and Amortization (D&A)	41	39	37	37	36	34	33	32	31	30
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	1.03%	2.88%	3.76%	-12.31%	-8.19%	2.09%	4.34%	1.59%	1.92%
Debt-free Net Working Capital to Revenue	2.42%	3.66%	5.41%	6.35%	-8.90%	-4.71%	6.13%	6.71%	5.33%	5.61%
Net Working Capital to Revenue	-0.01%	1.36%	3.23%	4.29%	-9.89%	-5.64%	5.27%	5.92%	4.51%	4.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.35	$0.74	$0.86	$0.84	$0.63	($2.39)	$0.79	$0.73	$0.69	$0.79
Adjusted Weighted Average Basic Shares Outstanding	91.62M	91.72M	91.63M	91.36M	90.95M	91.17M	91.04M	90.10M	89.68M	89.83M
Adjusted Diluted Earnings per Share	$0.36	$0.74	$0.85	$0.83	$0.64	($2.39)	$0.79	$0.72	$0.65	$0.78
Adjusted Weighted Average Diluted Shares Outstanding	92.06M	92.19M	92.04M	92.01M	90.95M	91.17M	91.55M	91.39M	91.56M	91.72M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	92.91M	92.89M	92.87M	92.77M	92.29M	92.22M	92.17M	92.03M	91.31M	90.98M
Normalized Net Operating Profit after Tax (NOPAT)	86	107	108	103	100	94	103	87	77	89
Normalized NOPAT Margin	11.13%	13.07%	13.61%	13.37%	13.45%	12.53%	14.09%	12.37%	11.43%	13.35%
Pre Tax Income Margin	4.91%	12.08%	13.37%	12.87%	10.77%	-38.30%	13.19%	12.16%	13.04%	14.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.26	4.29	4.65	4.63	0.00	-13.07	5.61	0.00	5.27	5.97
NOPAT to Interest Expense	2.00	3.11	3.53	3.69	0.00	-9.15	4.28	0.00	3.78	4.49
EBIT Less CapEx to Interest Expense	-4.50	-2.06	-0.60	-0.27	0.00	-19.24	1.28	0.00	1.04	1.73
NOPAT Less CapEx to Interest Expense	-4.76	-3.25	-1.72	-1.21	0.00	-15.32	-0.05	0.00	-0.45	0.26
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.12%	1.58%	121.08%	-177.65%	-32.61%	-28.35%	0.77%	0.20%	0.36%	0.58%
Augmented Payout Ratio	1.12%	1.57%	123.67%	-177.65%	-315.70%	-430.63%	18.06%	16.93%	4.54%	3.12%

Frequently Asked Questions About Acadia Healthcare's Financials

When does Acadia Healthcare's financial year end?

According to the most recent income statement we have on file, Acadia Healthcare's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Acadia Healthcare's net income changed over the last 9 years?

Acadia Healthcare's net income appears to be on an upward trend, with a most recent value of $264.48 million in 2024, rising from $111.48 million in 2015. The previous period was -$15.66 million in 2023. Check out Acadia Healthcare's forecast to explore projected trends and price targets.

What is Acadia Healthcare's operating income?

Acadia Healthcare's total operating income in 2024 was $458.25 million, based on the following breakdown:

Total Gross Profit: $1.46 billion
Total Operating Expenses: $1.00 billion

How has Acadia Healthcare revenue changed over the last 9 years?

Over the last 9 years, Acadia Healthcare's total revenue changed from $1.83 billion in 2015 to $3.15 billion in 2024, a change of 72.4%.

How much debt does Acadia Healthcare have?

Acadia Healthcare's total liabilities were at $2.77 billion at the end of 2024, a 11.9% increase from 2023, and a 6.9% increase since 2015.

How much cash does Acadia Healthcare have?

In the past 9 years, Acadia Healthcare's cash and equivalents has ranged from $11.22 million in 2015 to $378.70 million in 2020, and is currently $76.31 million as of their latest financial filing in 2024.

How has Acadia Healthcare's book value per share changed over the last 9 years?

Over the last 9 years, Acadia Healthcare's book value per share changed from 23.48 in 2015 to 33.09 in 2024, a change of 41.0%.

Related Companies

This page (NASDAQ:ACHC) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acadia Healthcare (ACHC) Financials

Frequently Asked Questions About Acadia Healthcare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acadia Healthcare (ACHC) Financials

Annual Income Statements for Acadia Healthcare

Quarterly Income Statements for Acadia Healthcare

Annual Cash Flow Statements for Acadia Healthcare

Quarterly Cash Flow Statements for Acadia Healthcare

Annual Balance Sheets for Acadia Healthcare

Quarterly Balance Sheets for Acadia Healthcare

Annual Metrics And Ratios for Acadia Healthcare

Quarterly Metrics And Ratios for Acadia Healthcare

Frequently Asked Questions About Acadia Healthcare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools